Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention

Objectivesthe aim of this study was to assess the diagnostic and prognostic value of heart-type fatty acid-binding protein (h-fabp) in elective percutaneous coronary intervention (pci) and compare it with standard cardiac markers.methodsa prospective evaluation was done of 80 consecutive patients admitted for elective pci. serum cardiac troponin t (ctnt), cardiac troponin i (ctni), creatine kinase-mb (ck-mb mass), myoglobin, and h-fabp were determined pre-angioplasty and 1, 2, 4, and 16–24 hrs post-angioplasty. elevated cardiac markers were correlated with demographic, angiographic and procedural variables. patients were followed up for 20–26 months.resultsh-fabp peaked early at 2 hours and was useful for the early detection of evolving ami within 1–3 hours after angioplasty. cardiac-tni, myoglobin, h-fabp, ck-mb mass, and ctnt concentrations were elevated in 46.25%, 17.5%, 13.3%, 11.25%, and 7.5% respectively. cardiac-tni was the most sensitive marker for detecting all complications and was superior to all other markers. elevated cardiac markers were correlated with old age (p < 0.02); chest pain ± ecg changes of ischaemia (p < 0.003); use of stents (p < 0.019) and major complications such as major dissection (p < 0.004); transient vessel closure (p < 0.022); bail out stent (p < 0.003), and ami (p < 0.042). elevated cardiac markers were associated with a reduction of event-free survival (16.92 versus 20.67 months, p < 0.03).conclusionheart-type-fabp measurements at 1 hour (or thereafter) post-pci may offer an early chance of detecting evolving ami; ctni was the most sensitive marker for the detection of major complications in patients undergoing pci. measurements of ctni 16–24 hours post-pci should be part of the routine management of patients following elective pci